There is a current demand for "safety signal" screening, not only for single drugs but also for drug-drug interactions. The detection of drug-drug interaction signals using the proportional reporting ratio () has been reported, such as through using the combination risk ratio (). However, the does not consider the overlap between the lower limit of the 95% confidence interval of the of concomitant-use drugs and the upper limit of the 95% confidence interval of the of single drugs. In this study, we proposed the concomitant signal score (), with the improved detection criteria, to overcome the issues associated with the . "Hypothetical" true data were generated through a combination of signals detected using three detection algorithms. The signal detection accuracy of the analytical model under investigation was verified using machine learning indicators. The presented improved signal detection when the number of reports was ≥3, with respect to the following metrics: accuracy (: 0.752 → : 0.817), Youden's index (: 0.555 → : 0.661), and -measure (: 0.780 → : 0.820). The proposed model significantly improved the accuracy of signal detection for drug-drug interactions using the .
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822185 | PMC |
http://dx.doi.org/10.3390/ph14010004 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!